Literature DB >> 16401856

Autologous peripheral blood stem cell transplantation for POEMS syndrome.

S Kuwabara1, S Misawa, K Kanai, Y Kikkawa, M Nishimura, C Nakaseko, R K Cho, T Hattori.   

Abstract

Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome is a rare multisystem disorder. Overproduction of vascular endothelial growth factor (VEGF) by plasmocytoma could be responsible for the symptoms. The authors treated four patients with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Within 6 months, symptoms associated with rapid normalization of serum VEGF levels improved.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16401856     DOI： 10.1212/01.wnl.0000188757.38495.23

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  23 in total

1.  Expression of vascular endothelial growth factor by plasma cells in the sclerotic bone lesion of a patient with POEMS syndrome.

Authors:  Hideto Nakajima; Shimon Ishida; Daisuke Furutama; Masakazu Sugino; Fumiharu Kimura; Taiji Yokote; Ichiro Baba; Motomu Tsuji; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2007-02-03       Impact factor: 4.849

Review 2.  Haematology and neurology.

Authors:  Steven Austin; Hannah Cohen; Nick Losseff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

3.  High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

Authors:  Gordon Cook; Simona Iacobelli; Anja van Biezen; Dimitris Ziagkos; Veronique LeBlond; Julie Abraham; Grant McQuaker; Stefan Schoenland; Alessandro Rambaldi; Kazimierz Halaburda; Maria Rovira; Simona Sica; Jenny Byrne; Ramon Garcia Sanz; Arnon Nagler; Niels W C J van de Donk; Marjatta Sinisalo; Mark Cook; Nicolaus Kröger; Theo De Witte; Curly Morris; Laurant Garderet
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

4.  Prominent dysautonomia in a patient with POEMS syndrome.

Authors:  Sharda Thakral; Naoum P Issa; Alexandru C Barboi; John M Lee
Journal:  Clin Auton Res       Date:  2016-05-11       Impact factor: 4.435

5.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 6.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 7.  Advances in the Treatment of Paraproteinemic Neuropathy.

Authors:  Eduardo Nobile-Orazio; Mariangela Bianco; Andrea Nozza
Journal:  Curr Treat Options Neurol       Date:  2017-10-16       Impact factor: 3.598

8.  Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome.

Authors:  Takehito Iwase; Hirotaka Yokouchi; Sonoko Misawa; Toshiyuki Oshitari; Takayuki Baba; Satoshi Kuwabara; Shuichi Yamamoto
Journal:  Neuroophthalmology       Date:  2017-05-19

9.  Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue.

Authors:  Hiroshi Kojima; Yuna Katsuoka; Yukitaka Katsura; Sachie Suzuki; Kazumi Suzukawa; Yuichi Hasegawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

10.  Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience.

Authors:  Il-Young Jang; Dok Hyun Yoon; Shin Kim; Kyoungmin Lee; Kwang-Kuk Kim; Young-Min Lim; Won-Ki Min; Cheolwon Suh
Journal:  Blood Res       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.